| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |